Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development

被引:40
作者
Alvarez-Saavedra, Matias [1 ]
Carrasco, Loreto [1 ]
Sura-Trueba, Sylvia [3 ]
Aiello, Vera Demarchi [2 ]
Walz, Katherina [1 ,4 ]
Xavier Neto, Jose [3 ]
Young, Juan I. [1 ,4 ,5 ]
机构
[1] Ctr Estudios Cient, Valdivia 5110246, Chile
[2] Univ Sao Paulo, Heart Inst InCor, Pathol Lab, BR-05403000 Sao Paulo, Brazil
[3] Univ Sao Paulo, Heart Inst InCor, Lab Genet & Mol Cardiol, BR-05403000 Sao Paulo, Brazil
[4] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL 33136 USA
[5] CIN Ctr Ingn Innovac CECS, Valdivia 5110246, Chile
关键词
CPG-BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; SEVERE MENTAL-RETARDATION; RETT-SYNDROME; DNA METHYLATION; BONE-FORMATION; ELECTROCARDIOGRAPHIC FINDINGS; CLEIDOCRANIAL DYSPLASIA; CYTOSINE METHYLATION; BDNF TRANSCRIPTION;
D O I
10.1093/hmg/ddq096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MeCP2 plays a critical role in interpreting epigenetic signatures that command chromatin conformation and regulation of gene transcription. In spite of MeCP2's ubiquitous expression, its functions have always been considered in the context of brain physiology. In this study, we demonstrate that alterations of the normal pattern of expression of MeCP2 in cardiac and skeletal tissues are detrimental for normal development. Overexpression of MeCP2 in the mouse heart leads to embryonic lethality with cardiac septum hypertrophy and dysregulated expression of MeCP2 in skeletal tissue produces severe malformations. We further show that MeCP2's expression in the heart is developmentally regulated; further suggesting that it plays a key role in regulating transcriptional programs in non-neural tissues.
引用
收藏
页码:2177 / 2190
页数:14
相关论文
共 100 条
[1]   Cardiac disease and Rett syndrome [J].
Acampa, M ;
Guideri, F .
ARCHIVES OF DISEASE IN CHILDHOOD, 2006, 91 (05) :440-443
[2]   A segment of the Mecp2 promoter is sufficient to drive expression in neurons [J].
Adachi, M ;
Keefer, EW ;
Jones, FS .
HUMAN MOLECULAR GENETICS, 2005, 14 (23) :3709-3722
[3]   A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype [J].
Adegbola, Abidemi A. ;
Gonzales, Michael L. ;
Chess, Andrew ;
LaSalle, Janine M. ;
Cox, Gerald F. .
HUMAN GENETICS, 2009, 124 (06) :615-623
[4]   Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis [J].
Alvarez-Saavedra, Matias ;
Saez, Mauricio A. ;
Kang, Dongcheul ;
Zoghbi, Huda Y. ;
Young, Juan I. .
HUMAN MOLECULAR GENETICS, 2007, 16 (19) :2315-2325
[5]   Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome [J].
Basson, CT ;
Bachinsky, DR ;
Lin, RC ;
Levi, T ;
Elkins, JA ;
Soults, J ;
Grayzel, D ;
Kroumpouzou, E ;
Traill, TA ;
LeblancStraceski, J ;
Renault, B ;
Kucherlapati, R ;
Seidman, JG ;
Seidman, CE .
NATURE GENETICS, 1997, 15 (01) :30-35
[6]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[7]   Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice [J].
Bissonnette, John M. ;
Knopp, Sharon J. ;
Maylie, James ;
Thong, Tran .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2007, 136 (1-2) :82-89
[8]   Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis [J].
Brown, DD ;
Martz, SN ;
Binder, O ;
Goetz, SC ;
Price, BMJ ;
Smith, JC ;
Conlon, FL .
DEVELOPMENT, 2005, 132 (03) :553-563
[9]   Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome [J].
Bruneau, BG ;
Logan, M ;
Davis, N ;
Levi, T ;
Tabin, CJ ;
Seidman, JG ;
Seidman, CE .
DEVELOPMENTAL BIOLOGY, 1999, 211 (01) :100-108
[10]   A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease [J].
Bruneau, BG ;
Nemer, G ;
Schmitt, JP ;
Charron, F ;
Robitaille, L ;
Caron, S ;
Conner, DA ;
Gessler, M ;
Nemer, M ;
Seidman, CE ;
Seidman, JG .
CELL, 2001, 106 (06) :709-721